Utility and limitations of metabolic parameters in head and neck cancer: finding a practical segmentation method
Entity
UAM. Departamento de CirugíaPublisher
SpringerDate
2022-05-02Citation
10.1007/s00405-022-07401-y
European Archives of Oto-Rhino-Laryngology (2022): 1-10
ISSN
0937-4477 (print); 1434-4726 (online)DOI
10.1007/s00405-022-07401-yFunded by
Open Access funding provided thanks to the CRUE-CSIC agreement with Springer NatureEditor's Version
https://doi.org/10.1007/s00405-022-07401-ySubjects
Cancer; Head and neck; MTV; PET; TLG; MedicinaRights
© The Author(s) 2022Abstract
Purpose: Although metabolic tumor volume (MTV) and total lesion glycolysis (TLG) have shown good prognostic value in head and neck cancer (HNC), there are still many issues to resolve before their potential application in standard clinical practice. The purpose of this study was to compare the discrimination ability of two relevant segmentation methods in HNC and to evaluate the potential benefit of adding lymph nodes’ metabolism (LNM) to the measurements. Methods: We retrospectively analyzed a recently published database of 62 patients with HNC treated with chemoradiotherapy. MTV and TLG were measured using an absolute threshold of SUV2.5. Comparison analysis with previously published background-level threshold (BLT) results was done through Concordance index (C-index) in eight prognostic models. Results: BLT obtained better C-index values in five out of the eight models. The addition of LNM improved C-index values in six of the prognostic models. Conclusion: We found a potential benefit in adding LNM to the main tumor measurements, as well as in using a BLT for MTV segmentation compared to the most commonly used SUV2.5 threshold. Despite its limitations, this study suggests a practical and simple manner to use these parameters in standard clinical practice, aiming to help elaborate a general consensus
Files in this item
Google Scholar:Rijo Cedeño, Jefferson
-
Mucientes, Jorge
-
Villarreal, Ithzel María
-
Royuela, Ana
-
García Vicente, Patricia
-
García Berrocal, José Ramón
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
García-Agúndez, José Augusto; Abad Santos, Francisco; Aldea, Ana; Alonso-Navarro, Hortensia; Bernal, María Luisa; Borobia Pérez, Alberto M.
; Borràs, Emma; Carballo, Miguel; Carvajal, Alfonso; García-Muñiz, José D.; Gervasini, Guillermo; Jiménez-Jiménez, Félix Javier; Lucena, María Isabel; Martínez, Carmen; Sacristán, José A.; Salado, Inés; Sinués, Blanca; Vicente, Jorge; García-Martín, Elena
2012-12-01 -
Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling
Cruz-Bermúdez, Alberto; Laza-Briviesca, Raquel; Vicente-Blanco, Ramiro J.; García-Grande, Aránzazu; Coronado, Maria José; Laine Menéndez, Sara; Alfaro, Cristina; Sánchez, Juan Cristóbal; Franco, Fernando; Calvo de Juan, Virginia
; Romero, Atocha; Martín-Acosta, Paloma; Salas, Clara; García, José Miguel; Provencio Pulla, Mariano
2018-11-01